Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03944798 · ClinicalTrials.gov registry record · NA
Surveillance AFter Extremity Tumor surgerY
A NA study of Soft Tissue Sarcoma and Lung Metastases, sponsored by McMaster University.
- Active
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 20
- Study locations
NCT03944798 is a NA study of Soft Tissue Sarcoma and Lung Metastases that is active but no longer recruiting, run by McMaster University. The registered enrollment target is 310 participants, above the 73-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (325% higher). The trial reports 20 study locations across 16 states.
The verdict
NCT03944798, a NA study of Soft Tissue Sarcoma and Lung Metastases, is active but no longer recruiting, sponsored by McMaster University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 20
- Study locations
Study Summary
Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patients. Therefore, careful post-operative surveillance is an integral element of patient care. However, the detection of metastases does not necessarily affect long-term survival and may negatively impact quality of life. Surveillance strategies have not been well researched and have been identified as the top research priority in the extremity sarcoma field. Using a 2X2 factorial design to maximize efficiency and reduce overall trial costs, the SAFETY trial randomized 310 extremity soft-tissue sarcoma (STS) patients to determine the effect of surveillance strategy on overall patient survival after surgery for a STS of the extremity by comparing the effectiveness of both surveillance frequency (every 3 vs. every 6 months) and imaging modality (CT scans vs. chest radiographs).
Conditions Studied
Interventions
- OTHER Frequency: Every 3 Months
- OTHER Frequency: Every 6 Months
- OTHER Imaging Modality: Chest Radiograph (CXR)
- OTHER Imaging Modality: Chest CT
Study Locations (20)
New York
- Albany Medical Center - Albany
- NYU Langone Orthopaedic Hospital/Perlmutter Cancer Center - New York
- Montefiore Medical Center - The Bronx
Other
- Hospital Universitario Austral - Buenos Aires
- LKH - Universitätsklinikum Graz - Graz
- Cliniques Universitaires Saint-Luc - Brussels
California
- University of California Davis Medical Center - Sacramento
Connecticut
- Hartford HealthCare - Hartford
Florida
- University of Florida Health Shands Hospital - Gainesville
Illinois
- UChicago Medicine - Chicago
Indiana
- Parkview Cancer Institute - Fort Wayne
Iowa
- Holden Comprehensive Cancer Center - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03944798
The ClinicalTrials.gov registry entry for NCT03944798 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 73-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (325% higher). The listed sponsor is McMaster University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Soft Tissue Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which Frequency: Every 3 Months is the first listed.
NCT03944798 reports 20 study locations spanning 16 distinct geographic areas - top geographies include New York, Other, California.
Frequently Asked Questions
What is clinical trial NCT03944798 about?
NCT03944798 is a clinical study titled "Surveillance AFter Extremity Tumor surgerY". Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patie...
What is the current status of trial NCT03944798?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 310 participants. The study started on 2019-11-19. Estimated completion is 2027-12.
What conditions does trial NCT03944798 study?
This clinical trial studies the following conditions: Soft Tissue Sarcoma, Lung Metastases.
What interventions are being tested in trial NCT03944798?
The interventions under investigation include: Frequency: Every 3 Months (OTHER), Frequency: Every 6 Months (OTHER), Imaging Modality: Chest Radiograph (CXR) (OTHER), Imaging Modality: Chest CT (OTHER).
Who is sponsoring clinical trial NCT03944798?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03944798 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Soft Tissue Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise and Soft Tissue Sarcoma
RECRUITING · NA
-
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
RECRUITING · NA
-
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
RECRUITING · NA
-
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
RECRUITING · NA
-
Pre-operative Hypofractionated Proton Therapy
RECRUITING · NA
-
Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.